| Literature DB >> 25373497 |
C Wallander1, J Frössling2, I Vågsholm1, A Uggla1, A Lundén1.
Abstract
Toxoplasma gondii is a zoonotic protozoan parasite, infecting a wide range of warm-blooded animals. The Swedish wild boar population is expanding and increased hunting provides its meat to a growing group of consumers. We performed a spatio-temporal investigation of T. gondii seroprevalence in Swedish wild boars. An ELISA was set up and evaluated against a commercial direct agglutination test, using Bayesian latent class analysis. The ELISA sensitivity and specificity were estimated to 79% and 85%, respectively. Of 1327 serum samples, 50% were positive. Thirty-four per cent of young wild boars and 55% of adults were positive (P < 0.001). The total seroprevalence ranged from 72% in 2005 to 38% in 2011 (P < 0.001), suggesting a declining trend. The highest seroprevalence, 65%, was recorded in South Sweden. In other regions it varied from 29% in Stockholm to 46% in East Middle Sweden.Entities:
Keywords: Monitoring; Toxoplasma gondii; serological screening; test evaluation; wild boar
Mesh:
Substances:
Year: 2014 PMID: 25373497 PMCID: PMC4456771 DOI: 10.1017/S0950268814002891
Source DB: PubMed Journal: Epidemiol Infect ISSN: 0950-2688 Impact factor: 2.451
Fig. 1.Geographical distribution of hunted wild boars in Sweden during the hunting seasons of 2009/2010 and 2010/2011. Based on data provided by the Swedish Association for Hunting and Wildlife Management, Wildlife Monitoring [9]. Colour scale represents number of animals hunted in each county (white areas represent no wild boars hunted). Regions (Nomenclature of Territorial Units for Statistics level 2) are drawn with black borders and black numbers on the map indicate percentage difference between proportion of hunted animals and proportion of sampled animals in each region. For example, South Sweden is underrepresented in our sample compared to the proportion of wild boars hunted in this region.
Number and distribution of serum samples per year, age group (in months) and region
| Variable | Category | 2005 | 2008 | 2009 | 2010 | 2011 | Total |
|---|---|---|---|---|---|---|---|
| Age | >12 | n.a. | n.a. | n.a. | 106 | 99 | 205 |
| ⩽12 | n.a. | n.a. | n.a. | 132 | 143 | 275 | |
| Unknown | n.a. | n.a. | n.a. | 12 | 28 | 40 | |
| Total | n.a. | n.a. | n.a. | 250 | 270 | 520 | |
| Region | South Sweden | 46 | 20 | 47 | 43 (23/18) | 12 (8/3) | 168 |
| Småland and the Islands | 19 | 121 | 63 | 45 (25/20) | 51 (21/27) | 299 | |
| West Sweden | 33 | 105 | 43 | 27 (16/10) | 18 (17/1) | 226 | |
| East Middle Sweden | 67 | 118 | 87 | 107 (46/54) | 144 (70/60) | 523 | |
| Stockholm | 3 | 5 | 8 | 27 (21/4) | 28 (22/5) | 71 | |
| North Middle Sweden | 12 | 0 | 0 | 1 (1/0) | 0 | 13 | |
| Unknown | 10 | 0 | 0 | 0 | 17 (5/3) | 27 | |
| Total | 190 | 369 | 248 | 250 | 270 | 1327 |
n.a., Not applicable.
Total number (⩽12 months/>12 months).
Fig. 2.Apparent seroprevalence (with 95% confidence intervals) in animals aged ⩽12 months and >12 months in 2010–2012.
Fig. 3.Apparent seroprevalence (with 95% confidence intervals) in different years.
Fig. 4.Apparent seroprevalence (with 95% confidence intervals) in different regions (Nomenclature of Territorial Units for Statistics level 2).
Fig. 5.Estimated (a) specificity and (b) sensitivity (including 95% credibility interval) of the in-house ELISA at different cut-offs, based on the latent class analysis.
Cross-classified test results from the in-house ELISA (cut-off 0·39) and the DAT on the 242 samples included in the latent class analysis
| Population 1 (⩽12 months) | Population 2 (>12 months) | |||||
|---|---|---|---|---|---|---|
| ELISA+ | ELISA− | Total | ELISA+ | ELISA− | Total | |
| DAT+ | 29 | 15 | 44 | 37 | 8 | 45 |
| DAT- | 13 | 86 | 99 | 10 | 44 | 54 |
| Total | 42 | 101 | 143 | 47 | 52 | 99 |
DAT, Direct agglutination test.
Results of latent class sensitivity analysis, showing mean posterior estimate (95% credible interval) for all estimated parameters, when analysed using priors for DAT (SeDAT/SpDAT), prevalences (π1/π2) and both
| Estimated characteristic | Prior used | ||
|---|---|---|---|
| SeDAT/SpDAT | π1/π2 | Both | |
| SeELISA | 76 (55–94) | 76 (46–95) | 79 (60–95) |
| SpELISA | 85 (73–96) | 82 (67–94) | 85 (74–94) |
| SeDAT | 79 (61–93) | 77 (43–98) | 82 (69–93) |
| SpDAT | 87 (78–95) | 83 (66–96) | 87 (80–94) |
| π1 | 27 (12–43) | 26 (19–34) | 27 (20–34) |
| π2 | 50 (33–72) | 43 (33–54) | 44 (34–59) |
DAT, Direct agglutination test.